News und Analysen
Mannatech Announces Appointment of James Clavijo as Chief Financial Officer
Mannatech, Incorporated (NASDAQ: MTEX) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024.
“Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply”
Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
Vistagen (Nasdaq: VTGN), a clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and
CI Financial Announces Election of Directors and Results of Annual Meeting of Shareholders
CI Financial Corp. (the “Corporation”) announces the results of matters voted upon at its annual meeting of shareholders held earlier today.
All nominated directors were elected with voting
Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances
Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary platform for probe-based and needle-based confocal laser endomicroscopy (p/nCLE)
CI Global Asset Management Announces Name Changes for Small/Mid-Cap Funds, and Risk Rating Changes
CI Global Asset Management (“CI GAM”) announces name changes for its suite of small/mid-cap equity funds, along with risk rating changes to three other funds.
Name changes
Effective June 21
EQS-News: Befesa has acquired the full ownership of French Recytech joint venture, moving forward with its strategic global growth plan in Europe
Granite REIT Notice of Conference Call for Second Quarter 2024 Results
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) expects to announce its financial results for the second quarter ended June 30, 2024 after the close of markets on
EQS-News: Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.
GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Granite REIT Declares Distribution for June 2024
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.275 per stapled unit for the month of
ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis
ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s only natural
CI Global Asset Management Announces June 2024 Distributions for CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending June 30, 2024 in respect of the CI ETFs. In all cases, the distribution will
CI Financial Reports Total Assets of $482.2 Billion for May 2024
CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $482.2 billion as at May 31, 2024, consisting of asset management assets of $129.5 billion, Canadian wealth
Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Vistagen (Nasdaq: VTGN), a neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development of groundbreaking therapies for psychiatric and neurological
CI Global Asset Management Launches U.S. Dollar Series of CI U.S. Quality Dividend Growth Index ETF
CI Global Asset Management (“CI GAM”) announces that CI U.S. Quality Dividend Growth Index ETF has closed its initial offering of ETF US$ Series Units, which begin trading today on the Toronto
Granite Real Estate Investment Trust and Granite REIT Inc. Announce Court Approval of Proposed Unwind of Stapled Unit Structure
Granite Real Estate Investment Trust (“Granite REIT”) and Granite REIT Inc. (“Granite GP”) (collectively, “Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that the Supreme Court of British
Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024
Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological
EQS-News: Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
Granite Announces Voting Results From Its 2024 Joint Annual General and Special Meetings of Stapled Unitholders
Granite Real Estate Investment Trust (“Granite REIT”) and Granite REIT Inc. (“Granite GP”) (collectively, “Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today the results of the matters voted on
EQS-News: Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
CI Financial Corp. Announces Pricing Terms of Cash Tender Offer for Any and All of its Outstanding 4.100% Notes due 2051
CI Financial Corp. (“CI” or the “Company”) (TSX: CIX) today announced the pricing terms for the previously announced cash tender offer (the “Tender Offer”) to purchase any and all of its
CI Financial Corp. Announces Early Results of Cash Tender Offer for Any and All of its Outstanding 4.100% Notes due 2051
CI Financial Corp. (“CI” or the “Company”) (TSX: CIX) today announced the early results of the previously announced cash tender offer (the “Tender Offer”) to purchase any and all of its outstanding
GenSight Biologics to Present at Upcoming Medical Conferences and Stakeholder Meetings
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal